Primit Parikh - Aug 30, 2023 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
President and CEO, Director
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Stock symbol
TGAN
Transactions as of
Aug 30, 2023
Transactions value $
$0
Form type
4
Date filed
9/1/2023, 04:04 PM
Previous filing
Jul 25, 2023
Next filing
Nov 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Award $0 +288K +129.64% $0.00 510K Aug 30, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TGAN Stock Option (right to buy) Award $0 +192K $0.00 192K Aug 30, 2023 Common Stock 192K $2.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU"). One twelfth (1/12) of the RSUs will vest on September 1, 2024, and the remaining RSUs vest in equal quarterly installments over the following 11 quarters, subject to the Reporting Person's continued service as of each such vesting date.
F2 One-fourth (1/4) of the shares subject to the option will vest on September 1, 2024, and the remaining shares vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service as of each such vesting date.